MP
Monalisa Padhi
About Monalisa Padhi
Data last updated:
Monalisa Padhi has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Evance Biosciences Private Limited and Lisapro Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Evance Biosciences Private Limited at ₹1.56 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Oct 2021 | 2021 | ₹1.56 Cr (FY 2025) | Active | |
| Director | 03 Jul 2024 | 2024 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Monalisa Padhi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monalisa Padhi
Monalisa Padhi has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Evance Biosciences Private Limited and Lisapro Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Evance Biosciences Private Limited at ₹1.56 Cr (FY 2025).
Monalisa Padhi is associated with 2 companies as Director, including Evance Biosciences Private Limited (₹1.56 Cr), Lisapro Biotech Private Limited.
Monalisa Padhi has expertise in General Business, Technology.
Monalisa Padhi has 5 years in corporate governance.
By reported revenue, the largest current company of Monalisa Padhi is Evance Biosciences Private Limited, with revenue of ₹1.56 Cr (FY 2025).
Monalisa Padhi currently holds positions at 2 companies: Evance Biosciences Private Limited (₹1.56 Cr), Lisapro Biotech Private Limited.